Literature DB >> 15661906

Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.

Connie M Krawczyk1, Russell G Jones, Alexandre Atfield, Kurt Bachmaier, Sudha Arya, Bernhard Odermatt, Pamela S Ohashi, Josef M Penninger.   

Abstract

The E3 ubiquitin ligase Casitas B cell lymphoma-b (Cbl-b) plays a critical role in the development of autoimmunity and sets the threshold for T cell activation. In the absence of Cbl-b, T cells stimulated via the TCR respond similarly to those that have received a CD28-mediated costimulatory signal, suggesting that the absence of Cbl-b substitutes for CD28-mediated costimulation. In this study, we show that loss of Cbl-b restores Ig class switching and germinal center formation in Vav1 mutant mice in response to an in vivo viral challenge. Genetic inactivation of Cbl-b also rescues impaired antiviral IgG production in CD28-mutant mice. Moreover, loss of CD28 results in disorganization of follicular dendritic cell clusters, which is also rescued by the Cbl-b mutation. Intriguingly, despite restored antiviral in vivo immunity and follicular dendritic cell clusters, loss of Cbl-b did not rescue germinal center formation in CD28-deficient mice. Mechanistically, in vivo vesicular stomatitis virus-induced IL-4 and IFN-gamma production and up-regulation of the inducible costimulatory molecule ICOS were dependent on CD28, and could not be rescued by the loss of Cbl-b. These data provide genetic evidence that CD28-dependent in vivo immune responses and Ig class switching can be genetically uncoupled from germinal center formation and ICOS induction by Cbl-b-Vav1-regulated signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661906     DOI: 10.4049/jimmunol.174.3.1472

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.

Authors:  Hui Guo; Guilin Qiao; Haiyan Ying; Zhenping Li; Yixia Zhao; Yanran Liang; Lifen Yang; Stanley Lipkowitz; Josef M Penninger; Wallace Y Langdon; Jian Zhang
Journal:  Cell Rep       Date:  2012-05-31       Impact factor: 9.423

Review 2.  Cbl-b in T-cell activation.

Authors:  Magdalena Paolino; Josef M Penninger
Journal:  Semin Immunopathol       Date:  2010-02-21       Impact factor: 9.623

3.  Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.

Authors:  Ingunn M Stromnes; Joseph N Blattman; Xiaoxia Tan; Sara Jeevanjee; Hua Gu; Philip D Greenberg
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

Review 4.  c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses.

Authors:  Christine B F Thien; Wallace Y Langdon
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

5.  Ndfip1 enforces a requirement for CD28 costimulation by limiting IL-2 production.

Authors:  Natalia Ramos-Hernández; Hilda E Ramon; Allison M Beal; Ami Laroche; Erin A Dekleva; Paula M Oliver
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

6.  CD43 regulates the threshold for T cell activation by targeting Cbl functions.

Authors:  Gustavo Pedraza-Alva; Lilia B Mérida; Roxana del Rio; Nora A Fierro; Mario E Cruz-Muñoz; Norma Olivares; Erika Melchy; Vivian Igras; Georg A Holländer; Steven J Burakoff; Yvonne Rosenstein
Journal:  IUBMB Life       Date:  2011-09-09       Impact factor: 3.885

Review 7.  Regulation of immune responses by E3 ubiquitin ligase Cbl-b.

Authors:  Rong Tang; Wallace Y Langdon; Jian Zhang
Journal:  Cell Immunol       Date:  2018-11-07       Impact factor: 4.868

Review 8.  E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.

Authors:  Qingjun Liu; Hong Zhou; Wallace Y Langdon; Jian Zhang
Journal:  Cell Cycle       Date:  2014-05-14       Impact factor: 4.534

9.  c-Cbl expression levels regulate the functional responses of human central and effector memory CD4 T cells.

Authors:  Nicolò C Brembilla; Johann Weber; Donata Rimoldi; Sylvain Pradervand; Frédéric Schütz; Giuseppe Pantaleo; Curzio Rüegg; Manfredo Quadroni; Keith Harshman; Marie-Agnès Doucey
Journal:  Blood       Date:  2008-05-27       Impact factor: 22.113

10.  p85beta phosphoinositide 3-kinase regulates CD28 coreceptor function.

Authors:  Isabela Alcázar; Isabel Cortés; Angel Zaballos; Carmen Hernandez; David A Fruman; Domingo F Barber; Ana C Carrera
Journal:  Blood       Date:  2009-02-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.